Gateway Biotechnology, Inc. is organized around developing nutraceutical products and drug re-purposing against hearing disorders. With ties to Washington University in St. Louis, principals of the firm had performed a functional drug screening of families of FDA-approved drugs for the prevention and treatment of noise-induced or age-related hearing loss. This lead to the discovery of a family of anti-epileptic drugs that could be used to prevent and treat both noise-induced and age-related hearing loss. Gateway Biotechnology, Inc. was established to enable the transition from these preclinical findings to clinical applications and treatments. ? One such hearing disorder is hearing loss as a side effect of cancer treatments. The success that we have already seen using this innovative technique has led the company to explore improved treatments for cancer drug, cisplatin. Working through an established technology platform to develop treatments bridging the gap between preclinical research and identification of leading drug candidates to prevent and treat diseases, the company has also developed three nutraceutical products based on extensive preclinical studies.
